| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/04/1996 | WO1996010081A1 Vaccine composition comprising recombinant bcg expressing gp63 fusion protein |
| 04/04/1996 | WO1996010080A1 Finderons and methods of their preparation and use |
| 04/04/1996 | WO1996010078A1 A monoclonal antibody to human ventricular myosin light chains |
| 04/04/1996 | WO1996010077A1 Monoclonal antibody to human cardiac myoglobin |
| 04/04/1996 | WO1996010075A1 Production of hydroxylated fatty acids in genetically modified plants |
| 04/04/1996 | WO1996010038A1 Multifunctional molecular complexes for gene transfer to cells |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996008274A3 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 04/04/1996 | WO1996005315A3 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 04/04/1996 | WO1996000288A3 Class bi and ci scavenger receptors |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | WO1995028482A3 Dna spacer regulatory elements responsive to cytokines and methods for their use |
| 04/04/1996 | DE4445562C1 Klonierung, Expression und Charakterisierung einer neuen Form der Phosphatidylinositol-3-Kinase Cloning, expression and characterization of a new form of phosphatidylinositol 3-kinase |
| 04/04/1996 | DE19536506A1 DNA encoding creatine amidinohydrolase |
| 04/04/1996 | CA2208599A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | CA2201485A1 Process of producing .beta.-lactam antibiotics applying microorganisms with increased ligase activity |
| 04/04/1996 | CA2201152A1 A monoclonal antibody to human ventricular myosin light chains |
| 04/04/1996 | CA2200973A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | CA2200963A1 Cell tests and diagnostic index for alzheimer's disease |
| 04/04/1996 | CA2200845A1 Finderons and methods of their preparation and use |
| 04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704540A2 Variety classification method for barley or malt using gene diagnosis and the primer used therefor |
| 04/03/1996 | EP0704534A2 Recombinant DNA viral vector for transfecting animal cells |
| 04/03/1996 | EP0704533A1 An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus |
| 04/03/1996 | EP0704532A2 Recombinant chimeric proteins and methods of use thereof |
| 04/03/1996 | EP0704531A2 Recombinant thermostable enzyme for converting maltose into trehalose |
| 04/03/1996 | EP0704530A2 A kanamycin resistance gene derived from microorganisms of the genus rhodococcus |
| 04/03/1996 | EP0704529A2 Vaccine against rabbit hemorrhagic disease virus |
| 04/03/1996 | EP0704528A2 Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing them |
| 04/03/1996 | EP0704527A2 DNA sequences encoding biosynthetic insulin precursors and process for prepation of insulin |
| 04/03/1996 | EP0704526A1 hTFIIIA gene |
| 04/03/1996 | EP0704458A2 Anti-human type IV collagen antibodies and use thereof |
| 04/03/1996 | EP0704457A1 Allergenic proteins of natural rubber latex, their production and use in assays |
| 04/03/1996 | EP0704243A1 Holder assembly for reaction tubes |
| 04/03/1996 | EP0704221A2 A conjugate useful in gene transfer and a method of producing the same |
| 04/03/1996 | EP0703989A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
| 04/03/1996 | EP0703988A1 Mesothelial cell gene therapy |
| 04/03/1996 | EP0703987A1 Chimeric plant genes possessing independent regulatory sequences |
| 04/03/1996 | EP0703986A1 Yeast promotor and use thereof |
| 04/03/1996 | EP0703985A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 04/03/1996 | EP0703984A1 Methods for screening of substances for therapeutic activity and yeast for use therein |
| 04/03/1996 | EP0703983A1 Regulation of plant growth |
| 04/03/1996 | EP0703982A1 Transgenic flowering plants |
| 04/03/1996 | EP0703981A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 04/03/1996 | EP0703980A1 Intracellular binding proteins and use thereof |
| 04/03/1996 | EP0703979A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
| 04/03/1996 | EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
| 04/03/1996 | EP0703825A1 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 04/03/1996 | EP0703789A1 Vaccine containing a serine protease |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0396608B1 Mutated subtilisin genes |
| 04/03/1996 | CN1119877A Novel pesticidal proteins and strains |
| 04/03/1996 | CN1119830A Antisense inhibition of C-MYC to modulate the proliferation of smooth muscle cells |
| 04/03/1996 | CN1031465C DNA clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 04/02/1996 | US5504200 Plant gene expression |
| 04/02/1996 | US5504198 Recombinant dna molecule coding for monoclonal antibody; diagnosis, treatment and prevention of disease |
| 04/02/1996 | US5504197 DNA encoding neurotrophic growth factors |
| 04/02/1996 | US5504008 Method for protein N-myristoylation |
| 04/02/1996 | US5504005 Recombinant mycobacterial vaccine |
| 04/02/1996 | US5503999 Virus resistant plants |
| 04/02/1996 | US5503998 Coating exogenous genetic construction including marker gene for insertion into soybean plants onto carrier particles, accelerating into plant tissue, regenerating shoots, assaying stem segments for expression, regenerating plants having gene |
| 04/02/1996 | US5503995 Syntehsis of dna based on cyclic mechanism of combining deoxypolynucleotides |
| 04/02/1996 | US5503993 Expressing and secreting mature human serum albumin by yeast transformed by recombinant dna comprising modified signal peptide gene which encodes modified signal peptide, promoter, terminator linked operably in proper reading frame |
| 04/02/1996 | US5503991 Vectors for use in filamentous fungi |
| 04/02/1996 | US5503987 Immunoassay for metallic cations and small organic molecules |
| 04/02/1996 | US5503981 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 04/02/1996 | US5503979 Determining presence or concentration of oligo- or polynucleotide in a sample |
| 04/02/1996 | US5503978 Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
| 04/02/1996 | US5503976 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and diagnostic typing processes and products related thereto |
| 04/02/1996 | US5503975 Mechanism based inhibitors of DNA methyltransferase |
| 04/02/1996 | US5503974 Exposing replication defective retroviral vector carried by primary cells to speciman, culturing primary cells with speciman, testing for recombinant retrovirus |
| 04/02/1996 | US5503834 Dna coding for measles virus hemagglutinin glycoprotein or fusion glycoprotein; protecting dogs from canine distemper |
| 04/02/1996 | US5503829 Recombinant adenylate cyclase of bordetella comprising at least one heterologous epitope inserted between amino acids 235 and 236 |
| 04/02/1996 | US5503816 Silicate compounds for DNA purification |
| 04/02/1996 | CA2066370C Yield when disulfide-bonded proteins are secreted |
| 04/02/1996 | CA1338207C Method of assaying of nucleic acids, a reagent combination and kit therefore |
| 03/30/1996 | CA2159411A1 Variety classification method for barley or malt using gene diagnosis and the primer used therefor |
| 03/28/1996 | WO1996009543A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | WO1996009410A1 Topographic genotyping |
| 03/28/1996 | WO1996009409A1 Enrichment of fetal cells from maternal blood |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009404A1 Method for preparing nucleic acids for analysis and kits useful therefor |
| 03/28/1996 | WO1996009400A1 Methods for genetically modifying hematopoietic stem cells |
| 03/28/1996 | WO1996009399A2 Chimeric adenovirus for gene delivery |
| 03/28/1996 | WO1996009398A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogens in crops |
| 03/28/1996 | WO1996009397A1 Gene encoding carboxypeptidase of aspergillus niger |
| 03/28/1996 | WO1996009396A1 Calcium free subtilisin mutants |
| 03/28/1996 | WO1996009395A2 Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases |
| 03/28/1996 | WO1996009394A1 Nucleic acid fragment and products derived therefrom |
| 03/28/1996 | WO1996009393A1 Dna sequence encoding squalene synthetase |
| 03/28/1996 | WO1996009392A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) [Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) [APO(a)] |
| 03/28/1996 | WO1996009391A2 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
| 03/28/1996 | WO1996009390A2 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | WO1996009389A2 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein |
| 03/28/1996 | WO1996009388A1 Novel anti-vh3-15 reagents, vh3-15 polypeptides, cell surface antigens, and methods for their detection and use |
| 03/28/1996 | WO1996009387A1 Cancer treatment by expression of differentiation factor receptor |
| 03/28/1996 | WO1996009386A2 Allelic variation of the serotonin 5ht2c receptor |